CW-2 Cells
CAD$897.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The CW-2 cell line is derived from human colorectal carcinoma. Established from the tumor tissue of a female patient, this cell line exhibits epithelial morphology and has been used primarily to study colorectal cancer mechanisms, including tumor growth, metastasis, and the tumor microenvironment. The CW-2 cells are known for their robust ability to form colonies in soft agar, indicating a high degree of tumorigenicity, which makes them a valuable model for in vitro experiments focusing on cancer aggressiveness and drug responses. Genetically, CW-2 cells carry mutations typical of colorectal cancers, such as alterations in the APC, KRAS, and TP53 genes. These mutations not only contribute to their malignant phenotype but also make them relevant for studies on genetic pathways involved in colorectal cancer progression and response to therapy. CW-2 has been instrumental in pharmacological research, providing insights into the efficacy and mechanism of action of various chemotherapeutic agents. Moreover, their response to environmental and genetic modifications can help in the development of targeted therapies for colorectal cancer. Due to the genetic profile and the aggressive nature of the CW-2 cell line, it is also utilized in research focusing on cancer stem cells and resistance to chemotherapy, offering a comprehensive model for understanding the dynamics of cancer treatment resistance and relapse. Research using CW-2 cells helps in deciphering the complex interactions within the tumor microenvironment that support cancer survival and proliferation, making them indispensable in advanced cancer research. |
|---|---|
| Organism | Human |
| Tissue | Colon |
| Synonyms | CW2 |
Characteristics
| Age | 55 years |
|---|---|
| Gender | Female |
| Ethnicity | Asian |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | CW-2 (Cytion catalog number 305134) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1151 |
Biomolecular Data
| Tumorigenic | Yes |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305134-281022 | Certificate of Analysis | 23. May. 2025 | 305134 |
| 305134-070425 | Certificate of Analysis | 23. May. 2025 | 305134 |